Friday 1 October 2021

Janssen Announces Start of Phase 3 Trial for Investigational Respiratory Syncytial Virus (RSV) Vaccine in Older Adults


Janssen Announces Start of Phase 3 Trial for Investigational Respiratory Syncytial Virus (RSV) Vaccine in Older Adults: https://ift.tt/3F5Itz2 Read more... https://ift.tt/3ilHcdy

No comments:

Post a Comment